每经头条（nbdtoutiao）——展望"十五五"|专访财科院院长杨志勇：遏制地方政府新增隐性债务，债务 信息要透明，尽可能降低利息成本 （记者 曾健辉） 2025年1至6月份，新天药业的营业收入构成为：主营收入占比99.9%，其他业务占比0.1%。 截至发稿，新天药业市值为28亿元。 每经AI快讯，新天药业（SZ 002873，收盘价：11.52元）11月14日晚间发布公告称，截至本公告日，新 天智药累计质押股数约为4804万股，占其所持股份比例为64.99%。 ...

证券代码：002873 证券简称：新天药业 公告编号：2025-059 贵阳新天药业股份有限公司 关于控股股东质押股份并解除部分质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 贵阳新天药业股份有限公司（以下简称"公司"）近日收到控股股东上海新 天智药生物技术有限公司（以下简称"新天智药"）的通知，新天智药对其持有 的公司部分股份进行了质押，并对部分已质押股份办理了解除质押手续，具体情 况如下： | 股东 | 是否控股 股东及一 | 本次质 押数量 | 占其所 持股份 | 占公司 总股本 | 是否为 | 是否 为补 | 质押 起始 | 质押 到期 | 质权人 | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 致行动人 | （股） | 比例 | 比例 | 限售股 | 充质 | 日 | 日 | | 用途 | | | | | | | | 押 | | | | | | 新天 | 是 | 2,430,00 | 3.29% | 1.00% | 否 | ...

南方财经11月14日电，新天药业(002873.SZ)控股股东上海新天智药生物技术有限公司于2025年11月12 日通过集中竞价交易减持800,000股，占总股本0.3277%，减持均价11.29元/股，对应金额约903万元。该 股东持股比例由32.0809%降至31.7409%，仍为公司第一大股东。 ...

本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002873 证券简称：新天药业 公告编号：2025-058 贵阳新天药业股份有限公司 关于控股股东减持股份触及1%的公告 公司控股股东上海新天智药生物技术有限公司保证向本公司提供的信息内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 ■ 贵阳新天药业股份有限公司（以下简称"公司"或"本公司"）于2025年10月21日披露了《关于控股股东拟 减持公司股份的预披露公告》（公告编号：2025-056），具体内容详见巨潮资讯网 （http://www.cninfo.com.cn）、《证券时报》等公司指定信息披露媒体。 贵阳新天药业股份有限公司 持有公司股份75,485,566股（占剔除公司回购专用账户中股份后总股本的32.0809%）的控股股东上海新 天智药生物技术有限公司（以下简称"新天智药"）计划通过大宗交易和集中竞价交易方式减持其持有的 本公司股份合计不超过7,050,000股，占剔除公司回购专用账户中股份后总股本的比例为2.9962%（其 中：通过大宗交易方式减持公司股 ...

（文章来源：证券日报） 证券日报网讯 11月13日晚间，新天药业发布公告称，近日，公司收到持有公司股份75，485，566股 （占剔除公司回购专用账户中股份后总股本的32.0809%）的控股股东上海新天智药生物技术有限公司 （以下简称"新天智药"）出具的《减持股份数量触及1%的告知函》，截至2025年11月12日，新天智药 已通过集中竞价交易方式减持公司股份共计800，000股，占公司总股本0.3277%，占剔除公司回购专用 账户中股份后总股本的比例为0.3400%。本次减持后，新天智药持有公司股份74，685，566股，持股比 例由32.0809%下降至31.7409%，权益变动触及1%。 ...

本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 贵阳新天药业股份有限公司（以下简称"公司"或"本公司"）于 2025 年 10 月 21 日披露了《关于控股股东拟减持公司股份的预披露公告》（公告编号：2025-056）， 具体内容详见巨潮资讯网（http://www.cninfo.com.cn）、《证券时报》等公司指定 信息披露媒体。 持有公司股份 75,485,566 股（占剔除公司回购专用账户中股份后总股本的 32.0809%）的控股股东上海新天智药生物技术有限公司（以下简称"新天智药"） 计划通过大宗交易和集中竞价交易方式减持其持有的本公司股份合计不超过 7,050,000 股，占剔除公司回购专用账户中股份后总股本的比例为 2.9962%（其中： 通过大宗交易方式减持公司股份不超过 4,700,000 股，占其持有公司股份总数的 6.2264%，占剔除公司回购专用账户中股份后总股本的 1.9975%；通过集中竞价交易 方式减持公司股份不超过 2,350,000 股，占其持有公司股份总数的 3.1132%，占剔除 公司回购专用账户中股份后总股本的 0.9987%）。 近日，公司收到新天 ...

新天药业公告称，公司控股股东新天智药于2025年10月21日计划减持不超705万股，占剔除回购专用账 户中股份后总股本的2.9962%。截至11月12日，新天智药已通过集中竞价交易减持80万股，占公司总股 本0.3277%，占剔除回购专用账户中股份后总股本的0.3400%。本次减持后，其持股比例由32.0809%降 至31.7409%，权益变动触及1%，且与此前减持计划和承诺一致。 ...

Core Viewpoint - The automotive industry is facing significant challenges, and 久车GO aims to reshape the supply chain through a three-pronged ecological strategy of "linking demand, optimizing ecology, and digital empowerment" to provide innovative solutions for industry transformation [1][2]. Group 1: Challenges in the Automotive Market - The current Chinese automotive sales system has notable irrationalities, with manufacturers and dealers under immense operational pressure due to systemic issues accumulated over time [2]. Group 2: Linking Demand - The lower-tier markets are identified as a key driver for growth in Chinese automotive consumption, with sales in fifth-tier cities increasing by 14.6% year-on-year, nearly three times the growth rate of first-tier cities [3]. - 久车GO has established a vast third-party fulfillment network, covering over 17,000 4S stores with a localized regulatory team of more than 5,800 people, effectively activating secondary dealers in county-level markets [3]. Group 3: Optimizing Ecology - The "direct connection between manufacturers and secondary networks" has transformed the traditional multi-level distribution model, significantly reducing redundant costs related to logistics, inventory, and capital occupation [4]. - The platform has served nearly 100 dealers across 14 provinces and 31 cities, managing over 40,000 units of D-class inventory with an asset value exceeding 5 billion yuan [4]. Group 4: Digital Empowerment - The platform serves as both a "digital distribution network" and a "market sensor" for manufacturers, while acting as an "intelligent empowerment platform" for dealers [5]. - For manufacturers, the platform creates a closed-loop sales data system, providing real-time decision support for product planning and inventory allocation, while for dealers, it helps in identifying and distributing high-quality customer leads [5]. - An example includes the 一汽丰田卡罗拉 project, where the platform facilitated over 27 million exposures and provided more than 7,500 high-quality leads monthly, achieving a conversion rate of approximately 3% [5]. Group 5: Ecological Vision - The goal of 久车GO is to establish not just a trading platform but a collaborative and win-win new ecosystem, integrating information, funds, and vehicles into an efficient closed loop [6]. - As a new retail platform developed by 长久股份, 久车GO is driving the digital transformation of the automotive supply chain through a dual approach of "online trading platform + offline county-level franchises," having facilitated over 1 million vehicle transactions and served more than 50,000 dealers by November 2025 [6].

Group 1 - New Tian Pharmaceutical (002873.SZ) released its Q3 2025 report on October 31, 2025, indicating that as of October 30, 2025, eight institutional investors held a total of 84.1289 million A-shares, accounting for 34.46% of the total share capital [1] - The proportion of shares held by institutional investors increased by 0.41 percentage points compared to the previous quarter [1] - Among public funds, the only fund that increased its holdings this period was the Huatai-PineBridge CSI Traditional Chinese Medicine ETF, with an increase of 0.11% [1] Group 2 - Two new foreign institutions disclosed their holdings this period, including CITIC Securities Asset Management (Hong Kong) Limited - Client Funds and Goldman Sachs [2] - UBS AG was not disclosed in this period compared to the previous quarter [2]

Core Points - The company and its board members guarantee the authenticity, accuracy, and completeness of the quarterly report, assuming legal responsibility for any misrepresentation or omissions [2][3] - The quarterly financial report has not been audited [3][6] - The company has made adjustments to its registered capital, increasing it from 231.491231 million yuan to 244.103806 million yuan [4] - The company has undergone a board member election and reform of the supervisory board [5] Financial Data - The company reported no non-recurring gains or losses during the quarter [3] - There were no adjustments or restatements of previous accounting data [3] - The financial report includes a consolidated balance sheet and profit statement for the period ending September 30, 2025 [5][6]